Characterizing inclusion and exclusion criteria in clinical trials for chimeric antigen receptor (CAR) T-cell therapy among adults with hematologic malignancies. uri icon

authors

  • Jaggers, Jordon L
  • Benson, Don M
  • Ashley E. Rosko, MD
  • Giri, Smith
  • Klepin, Heidi D
  • Wildes, Tanya M
  • Olin, Rebecca L
  • Andrew Artz, MD, MS
  • Wall, Sarah
  • Jaglowski, Samantha
  • William, Basem

publication date

  • January 1, 2020